Drupal-Bibcite31<style face="normal" font="default" size="100%">ENCHANTED Main Results - Trial of low-dose versus standard-dose intravenous tissue plasminogen activator in 3310 patients with acute ischaemic stroke [invited speaker]</style><style face="normal" font="default" size="100%">ENCHANTED Main Results - Trial of low-dose versus standard-dose intravenous tissue plasminogen activator in 3310 patients with acute ischaemic stroke [invited speaker]</style>